A pharmacometrics model to define docetaxel target in early breast cancer.
Azucena AldazPaula S SchaiquevichJosé Manuel AramendíaPublished in: British journal of clinical pharmacology (2022)
We report for the first time a relation between docetaxel exposure and toxicity and recommend specific targets of drug exposure with implications for the clinical management of early breast cancer patients.